Snapshot from Aug 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business Market Forecast

Medical Devices Market to Reach $829.69B by 2031

Analysis based on 8 articles · First reported Jul 21, 2026 · Last updated Aug 05, 2026

Sentiment
20
Attention
1
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The forecast signals sustained growth in the medical devices sector, potentially boosting investor confidence in major manufacturers. Companies with strong portfolios in in vitro diagnostics and presence in MSCI Asia Pacific Index may benefit from the projected expansion.

Medical Devices Healthcare Diagnostics

MarketsandMarkets released a market research report projecting the global top 10 medical devices market to grow from USD 637.42 billion in 2026 to USD 829.69 billion by 2031, at a CAGR of 5.4%. The growth is driven by increasing prevalence of chronic diseases, aging population, and demand for minimally invasive procedures. Technological advancements in AI-enabled diagnostics, robotic-assisted surgeries, and connected devices are transforming healthcare. In vitro diagnostic devices held the largest market share in 2025, and MSCI Asia Pacific Index is expected to register the highest growth. Key players include Medtronic, Johnson & Johnson, Olympus, B. Braun, Boston Scientific, Philips, GE HealthCare, Abbott, Zimmer Biomet Holdings, Smith & Nephew, and Stryker.

stock
Listed as a key player; expected to benefit from market growth.
Importance 80.0 Sentiment 60.0
stock
Key player; growth forecast positive for its medical devices segment.
Importance 80.0 Sentiment 60.0
stock
Key player; market expansion supports its endoscopy and other device lines.
Importance 70.0 Sentiment 55.0
priv
Key player; forecast indicates favorable conditions for its product portfolio.
Importance 70.0 Sentiment 55.0
stock
Key player; growth in cardiovascular and minimally invasive devices benefits it.
Importance 70.0 Sentiment 55.0
stock
Key player; imaging and connected devices align with market trends.
Importance 70.0 Sentiment 55.0
stock
Key player; imaging and diagnostics segments likely to grow.
Importance 70.0 Sentiment 55.0
stock
Key player; strong in in vitro diagnostics, the largest segment.
Importance 70.0 Sentiment 55.0
stock
Key player; broad portfolio across multiple device categories.
Importance 70.0 Sentiment 55.0
index
Expected to register highest growth due to infrastructure expansion and aging population.
Importance 70.0 Sentiment 60.0
stock
Key player; orthopedic devices demand expected to rise with aging population.
Importance 60.0 Sentiment 50.0
stock
Key player; wound care and orthopedic segments benefit from market growth.
Importance 60.0 Sentiment 50.0
priv
Largest regional market; growth continues but slower than MSCI Asia Pacific Index.
Importance 60.0 Sentiment 50.0
cnt
Part of North American Cobalt Inc., the largest regional market with 38.5% share.
Importance 50.0 Sentiment 40.0
cnt
Senior population projected to reach 230 million by 2036, boosting demand.
Importance 40.0 Sentiment 40.0
+ 3 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.